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STEM CELLS FROM PATIENTS WITH LATE OSTEOARTHRITIS
TOWARDS IN SITU JOINT CARTILAGE TISSUE ENGINEERING
J. Ringe, K. Gulich, T. Dehne, K. Andreas, G.-R. Burmester,
M. Sittinger. Tissue Engineering Lab. and Berlin-Brandenburg Ctr. for
Regenerative Therapies, Dept. of Rheumatology, Charité-Univ. Med.
Berlin, Berlin, Germany
Purpose: Today, for regenerative treatment of injured or early osteo-
arthritic cartilage, ACI and MACI are clinically applied. Also mesen-
chymal stem cell based approaches have reached the clinic. Here,
AMIC combines microfracture with implantation of a collagen
membrane, and Chondrotissue microfracture with a PGA/hyaluronan
scaffold. AMIC is a passive approach; endogenous MSC ﬂow into the
membrane. Chondrotissue, in whose development we were involved,
is between passive and active; MSC ﬂow into the scaffold is enhanced by
the addition of MSC recruiting serum. Our aim is to develop an active in
situ approach, wherein the implantation of scaffolds, loaded with MSC
recruiting chemokines and differentiation factors, combined with
microfracture, allows the use of endogenous MSC to promote OA
cartilage regeneration.
Methods: MSC were isolated from bone marrow of normal donor and
OA hip joint cancellous bone and characterized (morphology, growth,
surface marker, multilineage potential). Also their Ck receptor proﬁle
was elucidated (qPCR, immunohistochemistry). Cartilage and chon-
drocytes were harvested from ND and OA femoral heads, and super-
natants were analyzed for their Ck proﬁle (protein array). Then, the
recruitment potential of supernatants and Ck on MSC was examined
(chemotaxis assay), and Pertussis toxin, siRNA and antibodies were
applied to block Ck receptors. Moreover, expression proﬁles of Ckstimulated ND and OA MSC were generated and compared (micro-
arrays). Selected Ck were also encapsulated in a PLGA release system
using the w/o/w emulsion and solvent evaporation technique, and in
vitro and in vivo applied to chemoattract superparamagnetic iron oxide
nanoparticle (SPION) labeled MSC (rat model, MRI). Finally, compara-
tive gene expression proﬁling was performed for ND and OA MSC
ﬁbrinogen/PLGA transplants after chondrogenic stimulation with
TGFß3.
Results: ND and OA MSC have a ﬁbroblast-like morphology, a similar
doubling time, differentiate to fat, bone and cartilage, are CD73, CD105
positive, and CD45 negative. Moreover, both express most Ck receptors.
Proteomics revealed similar Ck proﬁles of ND and OA cartilage super-
natants. In contrast, ND and OA chondrocyte supernatants had different
Ck spectra. Only OA supernatants were CXCL12 (SDF1) positive. In
chemotaxis assays, cartilage supernatants recruited more MSC than
chondrocyte supernatants, and OA cartilage supernatants more MSC
than ND supernatants. Based on protein arrays, CCL25 (TECK) and was
analyzed in more detail. CCL25 recruited a high number of ND and OA
MSC and represents a candidate for in situ approaches. MSC treatment
with Pertussis toxin could block supernatant induced chemotaxis,
whereas treatment with CCR9-siRNA or CCR9-antibodies (the CCL25
receptor) had only a small effect. Subsequent expression proﬁling of
CCL25 induced ND and OA MSC gave us a deep insight into the Ck
dependent mobilization of these cells. For example, 22 genes were
differentially expressed in both ND and OA MSC. Most of them are
involved in pathways related to homing (PDE4B), cytoskeletal and
membrane reorganization (IGFBP1) and movement (CXCL8, PTGS2). In
an ongoing study, CCL25 loaded PLGA particles are tested in a rat model.
Here, for in vivo MRI monitoring of MSCmigration towards CK releasing
particles, SPION labeled MSC are used. Finally, the regenerative poten-
tial of OA and ND MSC was studied in ﬁbrinogen/PLGA transplants.
Chondrogenesis resulted in ﬁbro- and joint cartilage. Moreover, ND and
OA expression proﬁles showed a similar expression of marker genes
known in context of OA (COL10A1, MMP1 and -3).
Conclusions: Here we have shown that end-stage OA MSC behave like
ND MSC, and that we have established the key knowledge and tools for
an active, MSC-based in situ therapy of injured or OA joint cartilage. In
future, addition of anti-inﬂammatory drugs may allow the use of such
approaches during inﬂammation and thus, also for other arthritic
diseases like RA.600
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Purpose: In vitro models are useful tools for the development of new
therapy strategies in cartilage repair. The limited availability of human
primary tissue and high costs of animal models hamper preclinical tests
of innovative substances and techniques. In this study we tested the
potential of porcine chondrocyte micromasses to mimic essential
aspects of osteoarthritis (OA) in vitro.
Methods: Primary chondrocytes were enzymatically isolated from
porcine femoral condyle and were maintained for 14 days in 96-mul-
tiwell format to establish cartilage-like extracellular matrix (ECM) in
a high-throughput scale. Subsequently, 10ng/ml recombinant porcine
tumor necrosis factor alpha (TNF-alpha) was added up to 14 days to
induce OA changes. These changes were documented on histological
(Alcian blue and Safranin O stainings histomorphometrically analyzed),
biochemical (collagens: hydroxyproline assay, proteoglycans: DMMB-
method) and gene expression level (Affymetrix porcine microarray, RT-
PCR), and were compared with data from human OA cartilage. Further,
the inﬂuence of 10 ng/ml transforming growth factor beta 1 (TGF-b1), 1
ng/ml interleukin 1 beta (IL-1b) and 5% platelet rich plasma (PRP) on
TNF-alpha induced changes was analyzed to test the performance of the
model.
Results: After 14 days in micromass culture, porcine primary chon-
drocytes developed an ECM rich in proteoglycans and collagens. On
gene expression level cartilage markers COL2A1, COMP, CSPG4 and
Aggrecan were detected. After stimulation with 10 ng/ml TNF-alpha,
